ClearPoint Neuro, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Stock Options Issued by the Company

	Shares			Weighted- average Exercise price per share		Intrinsic Value⁽¹⁾(in thousands)
Outstanding at January 1, 2021		1,806,092		$	7.12	$	20,760
Exercised		(416,900	)		2.60
Outstanding at March 31, 2021		1,389,192		$	8.46	$	21,516

⁽¹⁾

Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.

Schedule of Common Stock Warrant Activity

	Shares			Weighted- average Exercise price per share		Intrinsic Value⁽¹⁾(in thousands)
Outstanding at January 1, 2021		3,082,987		$	3.82	$	37,379
Exercised		(1,150,647	)		2.31
Outstanding at March 31, 2021		1,932,340		$	4.72	$	31,778

⁽¹⁾

Intrinsic value is calculated as the estimated fair value of the Company’s stock at the end of the related period less the option exercise price of in-the-money options.